COR:NYSE
Cencora Inc
$313.12
arrow_downward
-0.57%(-1.81) 1D
Oct 6, 1:21:29 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for COR...
Open
$314.63
High
$316.14
Low
$311.83
Mkt. cap
13.84B
Avg. vol.
1.26M
Volume
247.80K
52-wk high
$377.54
52-wk low
$244.82
Beta
0.58
Shares outstanding
190.83M
No. of employees
49K
Open
$314.63
High
$316.14
Low
$311.83
Mkt. cap
13.84B
Avg. vol.
1.26M
Volume
247.80K
52-wk high
$377.54
52-wk low
$244.82
Beta
0.58
Shares outstanding
190.83M
No. of employees
49K
News stories
From web sources and news partners
AD HOC NEWS
·
1 hour ago
Cencora stock carries an 18.2 percent analyst upside
Investing.com Canada
·
7 hours ago
Form 4 Cencora Inc For: 6 October By Investing.com
Stock Titan
·
19 hours ago
A 275-share stock grant for Cencora (COR) director Robert E. Sanchez vests in one year.
News Corp
·
20 hours ago
Cencora Inc. stock outperforms competitors on strong trading day
Profile
Cencora, Inc., formerly known as AmerisourceBergen, is an American drug wholesale and distribution company and a contract research organization, that was formed by the merger of Bergen Brunswig and AmeriSource in 2001. It was renamed to Cencora in 2023. Cencora is one of the largest pharmaceutical companies in the world and distributes generic pharmaceuticals, over-the-counter healthcare products, as well as home healthcare supplies and equipment. The company is headquartered in Conshohocken, Pennsylvania, part of the Philadelphia metropolitan area. Wikipedia
About Cencora Inc